Slides
Page 1
Orchid Pharma LimitedFinancials Q2 FY-26 •All results in standalone basis.•These are approx. or exact nos. pls refer financials for details.
Page 2
Financial Performance(Amt. in Cr.) Q2-26 Q2-25 Change % H1-26 H1-25 % ChangeSales194 223-13%366467-22%Other Income15 8+88%3116+94%COGS132 131+1%231281-18%Employee Exp24 21+14%4642+10%Other Exp38 41-7%7681-6%EBITDA*15 38-61%4479-44%% to Sales8% 17% 12%17%Interest 4 3+33%770%Depreciation9 90%17170%PBT2 26-92%2055-64%PAT2 26-92%2055-64%
Page 3
Turnover (Amt. in Cr.) 122 165 199 223 194 - 50 100 150 200 250 Q2-22 Q2-23 Q2-24 Q2-25 Q2-26
Page 4
EBIDTA, PBT & PAT as % to Sales Q2-26 Q2-22 Q2-23 Q2-24 Q2-25 Q2-26EBITDA8% 15% 16% 17% 8%PBT-17% -2% 10% 11% 1%PAT-17% -2% 10% 11% 1%8%15%16%17%8%-17%-2%10%11%1%-17%-2%10%11%1%-20%-15%-10%-5%0%5%10%15%20% EBITDAPBTPAT
Page 5
P&L Analysis – Gross Margin % to Sales Q2-26 41%39%38%41%32%0%5%10%15%20%25%30%35%40%45% Q2-22 Q2-23 Q2-24 Q2-25 Q2-26
Page 6
P&L Analysis – Exp. % to Sales Q2-26 13%11%9%9%12%22%18%18%19%20%0%5%10%15%20%25%Q2-22 Q2-23 Q2-24 Q2-25 Q2-26Emp BenefitOther Exp
Page 7
Thank You